Literature DB >> 7391029

Studies on a soluble human erythrocyte protein kinase.

K W Simkowski, M Tao.   

Abstract

A cyclic AMP-independent protein kinase has been isolated from human erythrocyte cytosol and purified about 28,000-fold. The enzyme uses ATP as the phosphoryl donor and exhibits a high activity towards casein and phosvitin. The kinase has a molecular weight of about 30,000 to 32,000 as estimated by sucrose density gradient centrifugation and Sephacryl S-200 gel filtration. Upon isoelectrofocusing, two kinase activities are resolved. The major component, which comprises about 85% of the activities, focuses at a pH of about 9.6 and the minor component at about 4.6. The relationship between these two kinase activities is not clear. NaF, ADP and, to a lesser extent, AMP, all inhibit the kinase activity. 2,3-Diphosphoglyceric acid, on the other hand, has no effect. The kinase also catalyzes the phosphorylation of a number of erythrocyte membrane proteins, including spectrin, band 3, and the sialoglycoproteins.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7391029

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

Review 1.  Role of the phosphorylation of red blood cell membrane proteins.

Authors:  P Boivin
Journal:  Biochem J       Date:  1988-12-15       Impact factor: 3.857

2.  Phosphorylation of cytosolic proteins by casein kinases in human erythrocytes. Response to ionic strength and to 2,3-bisphosphoglycerate.

Authors:  G Clari; V Moret
Journal:  Mol Cell Biochem       Date:  1987-04       Impact factor: 3.396

3.  Phosphorylation of membrane proteins by cytosolic casein kinases in human erythrocytes. Effect of monovalent ions, 2,3-bisphosphoglycerate and spermine.

Authors:  G Clari; V Moret
Journal:  Mol Cell Biochem       Date:  1985-10       Impact factor: 3.396

4.  Metabolic control of the K+ channel of human red cells.

Authors:  P J Romero; C E Ortíz; C Melitto
Journal:  J Membr Biol       Date:  1990-06       Impact factor: 1.843

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.